Anti-Spike-RBD-fully-human-mAb(IgG) |
E24AHA001 |
EnoGene |
Human,-Human-IgG1.Affinity:(mol)4.15*10-10(Fortebio),-1.07-nM(ELISA).-FACs-Blocking:-0.892-nM- |
EUR 416.5 |
Description: Human, Human IgG1.Affinity: (mol) 4.15*10-10 (Fortebio), 1.07 nM (ELISA) . FACs Blocking: 0.892 nM |
Human IgG antibody Laboratories manufactures the glycoprotein spike factors reagents distributed by Genprice. The Glycoprotein Spike Factors reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike Glycoprotein. Other Glycoprotein products are available in stock. Specificity: Glycoprotein Category: Spike Group: Factors
Anti-Spike-RBD-fully-human-mAb(IgG) |
EnoGene |
Humanized-Monoclonal-Antibody.-human-IgG1.-Affinity:0.762-nM(By-ELISA) |
EUR 416.5 |
Description: Humanized Monoclonal Antibody. human IgG1. Affinity:0.762 nM (By ELISA) |
Anti-SARS-CoV-2 Antibody IgG Quantitative and Titer Detection Kit (Spike RBD) |
ACROBIOSYSTEMS |
96tests |
EUR 845.3 |
|
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective Assay kit detecting the levels of anti-SARS-CoV-2 in human serum can facilitate research on characterization of antibodies produced in response to SARS-CoV-2 infection. |
Anti-SARS-CoV-2 Antibody IgG Quantitative and Titer Detection Kit (Spike Trimer) |
ACROBIOSYSTEMS |
96tests |
EUR 845.3 |
|
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective Assay kit detecting the levels of anti-SARS-CoV-2 in human serum can facilitate research on characterization of antibodies produced in response to SARS-CoV-2 infection. |
Anti-SARS-CoV-2 Antibody IgG Quantitative and Titer Detection Kit (Spike S1) |
ACROBIOSYSTEMS |
96tests |
EUR 845.3 |
|
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective Assay kit detecting the levels of anti-SARS-CoV-2 in human serum can facilitate research on characterization of antibodies produced in response to SARS-CoV-2 infection. |
JBS True Blue |
MiTeGen |
300 µl |
EUR 16 |
Description: JBS True Blue |
Factors information
Spike Glycoprotein Polyclonal Antibody, HRP Conjugated |
A57202 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
Spike Glycoprotein Polyclonal Antibody, HRP Conjugated |
A56215 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
SARS-CoV-2 Spike Glycoprotein S1 SF9 Cell Line |
T6797 |
ABM |
1x10^6 cells/1.0ml |
Ask for price |
SARS-CoV-2 Spike Glycoprotein S2 SF9 Cell Line |
T6798 |
ABM |
1x10^6 cells/1.0ml |
Ask for price |
Rabbit anti-COVID-19 Spike glycoprotein Antibody |
DL99721A-100ul |
DL Develop |
100 ul |
EUR 299 |
|
Description: Spike glycoprotein; S glycoprotein; E2; Peplomer protein |
Rabbit anti-COVID-19 Spike glycoprotein Antibody |
DL99721A-50ul |
DL Develop |
50 ul |
EUR 210 |
|
Description: Spike glycoprotein; S glycoprotein; E2; Peplomer protein |
Spike Glycoprotein Polyclonal Antibody, FITC Conjugated |
A57203 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
Spike Glycoprotein Polyclonal Antibody, FITC Conjugated |
A56216 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
Human Novel Coronavirus Spike glycoprotein(S),partial |
30-2012 |
Fitzgerald |
100 ug |
EUR 675 |
|
Description: Recombinant Human Novel Coronavirus Spike glycoprotein(S),partial |
Spike Glycoprotein Polyclonal Antibody, Biotin Conjugated |
A57204 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
Spike Glycoprotein Polyclonal Antibody, Biotin Conjugated |
A56217 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
SARS Coronavirus Spike Glycoprotein (S1), His-Tag (HEK293) |
REC31809-100 |
The Native Antigen Company |
0.1 |
EUR 482.23 |
Description: Recombinant severe acute respiratory syndrome virus Spike S1 protein produced in HEK293 cells and purified from culture supernatant by immobilised metal affinity and ion exchange chromatography. |
SARS Coronavirus Spike Glycoprotein (S1), His-Tag (HEK293) |
REC31809-500 |
The Native Antigen Company |
0.5 |
EUR 1837.08 |
Description: Recombinant severe acute respiratory syndrome virus Spike S1 protein produced in HEK293 cells and purified from culture supernatant by immobilised metal affinity and ion exchange chromatography. |
SARS-CoV-2 Spike Glycoprotein (S1), Sheep Fc-Tag (CHO) |
REC31869-100 |
The Native Antigen Company |
0.1 |
EUR 496.27 |
Description: Recombinant SARS-CoV-2 Spike Glycoprotein S1, C-terminally tagged with a sheep Fc-tag. Protein was produced in CHO cells and purified from culture supernatant by Protein G chromatography. |
SARS-CoV-2 Spike Glycoprotein (S1), Sheep Fc-Tag (CHO) |
REC31869-1000 |
The Native Antigen Company |
1 |
EUR 1885.56 |
Description: Recombinant SARS-CoV-2 Spike Glycoprotein S1, C-terminally tagged with a sheep Fc-tag. Protein was produced in CHO cells and purified from culture supernatant by Protein G chromatography. |
SARS-CoV-2 Spike Glycoprotein (S1), Sheep Fc-Tag (CHO) |
REC31869-500 |
The Native Antigen Company |
0.5 |
EUR 1885.56 |
Description: Recombinant SARS-CoV-2 Spike Glycoprotein S1, C-terminally tagged with a sheep Fc-tag. Protein was produced in CHO cells and purified from culture supernatant by Protein G chromatography. |
SARS-CoV-2 Spike Glycoprotein (S2), Sheep Fc-Tag (CHO) |
REC31870-100 |
The Native Antigen Company |
0.1 |
EUR 496.27 |
Description: Recombinant SARS-CoV-2 Spike Glycoprotein S2, C-terminally tagged with a sheep Fc-tag. Protein was produced in CHO cells and purified from culture supernatant by Protein G chromatography. |